Finance

Lists
Why is HHB0 down 5.73%?
Dive Deeper
HHB0:FRA
X T L Biopharmaceuticals Ltd
€1.48
-5.73%
(-0.090) 1D
Oct 15, 8:04:09 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HHB0...
Open
€1.48
High
€1.48
Low
€1.48
Mkt. cap
27.04M
Avg. vol.
0.00
Volume
0.00
52-wk high
€3.24
52-wk low
€1.48
No. of employees
5
Open
€1.48
High
€1.48
Low
€1.48
Mkt. cap
27.04M
Avg. vol.
0.00
Volume
0.00
52-wk high
€3.24
52-wk low
€1.48
No. of employees
5
News stories
From web sources and news partners
About X T L Biopharmaceuticals Ltd
CEO-
Employees5
Founded1993
HeadquartersHerzliya, Tel Aviv District, Israel
SectorBiotechnology
Websitextlbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
258.50K
258.50K
-
-
Cost of goods sold
1.39M
1.39M
-
-
Cost of revenue
1.39M
1.39M
-
-
Research and development expenses
10.50K
10.50K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
956.00K
956.00K
-
-
Operating expense
1.08M
1.08M
-
-
Total operating expenses
2.46M
2.46M
-
-
Operating income
-2.21M
-2.21M
-
-
Other non operating income
500.00
500.00
-
-
EBT including unusual items
-2.86M
-2.86M
-
-
EBT excluding unusual items
-2.23M
-2.23M
-
-
Income tax expense
-109.50K
-109.50K
-
-
Effective tax rate
3.83%
3.83%
-
-
Other operating expenses
111.50K
111.50K
-
-
Net income
-2.75M
-2.75M
-
-
Net profit margin
-1,063.83%
-1,063.83%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-25.50K
-25.50K
-
-
Net interest expenses
-25.50K
-25.50K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.16M
-2.16M
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps